Goodwin Charles D. II
- SEC CIK
- 0001726988
No open-market purchases or sales filed in the past year.
Current role at each company
- APYX Apyx Medical CorpChief Executive Officeras of Jun 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Goodwin Charles D. II as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 (view filing) | Nov 14 | 1 day | Goodwin Charles D. IIChief Executive Officer | PPurchase | +50.0K | $1.57 | +$78.5K | +125.0%90.0K after | |
| Aug 31, 2022 (view filing) | Aug 29 | 2 days | Goodwin Charles D. IIChief Executive Officer | PPurchase | +11.8K | $5.96 | +$70.1K | +41.6%40.0K after | 2 lots |